Gliflozines in active cancer patients with heart failure: final results on safety and effectiveness in the observational TOSCA trial
Event: ESC Cardio-Oncology 2025
Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer
Session: Novel strategies for prevention in cardio-oncology
Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction
Event: EuroEcho-Imaging 2018
Topic: Systolic and Diastolic Function
Session: Echocardiography: Systolic and Diastolic Function
Interactive role of diastolic dysfunction and ventricular remodeling in stage A and B heart failure with preserved ejection fraction: impact on clinical practice
Event: EuroEcho-Imaging 2018
Topic: Systolic and Diastolic Function
Session: Echocardiography: Systolic and Diastolic Function
Interactive role of diastolic dysfunction and ventricular remodeling in stage a and b heart failure with preserved ejection fraction: impact on clinical practice
Event: ESC Congress 2018
Topic: Diastolic Ventricular Dysfunction
Session: Chronic heart failure – Pathophysiology and mechanisms
Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction
Event: ESC Congress 2018
Topic: Ventricular Remodelling
Session: Chronic heart failure – pathophysiology and mechanisms
